Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 923 entries
View as:

Diagnostic Utility of Pleural Fluid MAGE Assay in Patients With Pleural Effusion From Primary Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01179685 Org: User:
Start: 01/31/09 End: 12/31/10 Due: 12/31/11

Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00767754 Org: User:
Start: 01/31/07 End: 12/31/08 Due: 12/31/09

Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator

Phase: N/A Priority: Normal
NCT ID: NCT05527717 Org: User:
Start: 11/16/22 End: 12/31/28 Due: 12/31/29

Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor

Phase: N/A Priority: Normal
NCT ID: NCT04932343 Org: User:
Start: 06/01/21 End: 12/01/22 Due: 12/01/23

Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02060669 Org: User:
Start: 06/20/10 End: 09/30/14 Due: 09/30/15

External Validation of Prediction Algorithm Using Non-invasive Monitoring Device for Intraoperative Hypotension

Phase: N/A Priority: Normal
NCT ID: NCT06897514 Org: User:
Start: 04/11/25 End: 12/31/25 Due: 12/31/26

Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

Phase: N/A Priority: Normal
NCT ID: NCT03822520 Org: User:
Start: 06/30/17 End: 05/25/18 Due: 05/25/19

Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02688907 Org: User:
Start: 06/07/16 End: 09/12/18 Due: 09/12/19

Influence of Tidal Volume During Mechanical Ventilation on Postoperative Clinical Outcome in Pediatric Patients Undergoing Congenital Heart Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02081274 Org: User:
Start: 01/31/14 End: 12/31/16 Due: 12/31/17

Identification the Cause of Cerebral Infarction in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02212496 Org: User:
Start: 08/31/14 End: 03/31/18 Due: 03/31/19

Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)

Phase: N/A Priority: Normal
NCT ID: NCT06461793 Org: User:
Start: 09/12/23 End: 12/31/33 Due: 12/31/34

Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02447419 Org: User:
Start: 12/03/14 End: 12/01/20 Due: 12/01/21

Phase II of Lenalidomide After Salvage Therapy in R/R Non-Hodgkin T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03730740 Org: User:
Start: 11/16/18 End: 11/30/23 Due: 11/30/24

Real World Difference After Changing Medication From Nonselective to Selective Endothelin Receptor Antagonist in Stable Eisenmenger Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04732650 Org: User:
Start: 02/04/21 End: 12/31/24 Due: 12/31/25

Clinical Evaluation of the Needleless® Sling

Phase: N/A Priority: Normal
NCT ID: NCT01054833 Org: User:
Start: 01/31/10 End: 02/28/13 Due: 02/28/14

Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy

Phase: N/A Priority: Normal
NCT ID: NCT01483417 Org: User:
Start: 12/31/11 End: 03/31/13 Due: 03/31/14

Adjuvant Durvalumab for Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02520453 Org: User:
Start: 02/29/16 End: 12/31/21 Due: 12/31/22

Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

Phase: N/A Priority: Normal
NCT ID: NCT01043250 Org: User:
Start: 05/31/09 End: 12/31/10 Due: 12/31/11

Phase IV Study to Evaluate the Efficacy and Safety of Mircera in PD

Phase: N/A Priority: Normal
NCT ID: NCT01807481 Org: User:
Start: 03/31/13 End: 08/31/15 Due: 08/31/16

High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study

Phase: N/A Priority: Normal
NCT ID: NCT01083342 Org: User:
Start: 01/31/10 End: 05/31/12 Due: 05/31/13

The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03399669 Org: User:
Start: 02/17/15 End: 12/31/18 Due: 12/31/19

Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01066286 Org: User:
Start: 02/28/10 End: - Due: -

Timely Acquirement of 12-lead ECG Using Patchy-type Wireless Device Among Patient With Chest Pain

Phase: N/A Priority: Normal
NCT ID: NCT04048733 Org: User:
Start: 07/30/19 End: 12/16/19 Due: 12/16/20

Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT03381872 Org: User:
Start: 05/10/18 End: 12/31/22 Due: 12/31/23

Adjuvant CCRT vs CT in Minimal N2 NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT01066234 Org: User:
Start: 10/23/17 End: 01/18/21 Due: 01/18/22